Abstract
Both in histologically proven (N = 3) and clinically diagnosed (N = 3) definite (peri)myocarditis in children, as well as in probable (N = 6) and possible inflammatory perimyocardial disease (N = 31), antibodies directed against the sarcolemma and myolemma (AMLAs) were demonstrated. In the acute phase AMLAs of the IgM class and complement fixation prevailed in the serum and the biopsy specimens. Complement dependent cytolysis by the patients' sera in the acute phase may simulate in vitro what could also be operative in vivo: a secondary immunopathogenesis due to cytolytic antimembrane antibodies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
